“…In addition to its well‐known antioxidant properties [reviewed in (Ross & Siegel, 2017)], NQO1 exerts significant metabolic functions by conferring protection against obesity, hypertension, arterial restenosis, renal injury, and neurodegenerative disorders (Chhetri, King & Gueven, 2017; Hwang et al., 2009; Kim et al., 2011; Son et al., 2015). The C609T (Pro187Ser) null polymorphism of the NQO1 gene is associated with increased risk of complications related to metabolic syndrome, Alzheimer's disease, and an overall increased risk of cancer in humans (Chhetri et al., 2017; Lajin & Alachkar, 2013; Martinez‐Hernandez et al., 2015; Ramprasath et al., 2012). Genetic ablation of NQO1 in rodent models also increases sensitivity to skin carcinogenesis (Iskander et al., 2005) and causes severe dysregulation of lipid and glucose metabolism (Gaikwad, Long, Stringer & Jaiswal, 2001).…”